Facebook event page | Hashtags: #WorldDentalCongress & #FDI2017Madrid
cabecera

Symposium on anaesthesia

Stanley F. Malamed (USA)
Elliott Hersh (USA)

Time: 10:30 - 13:00
Room: MIRO (PV7)
Language: English
Chair(s): Edward Allan Kalyesubula (Uganda)
CERP: 2.5

WHAT'S NEW IN DENTAL LOCAL ANESTHESIA
Stanley F. Malamed (USA)

Learning Objectives

  • > Describe the mechanism of action and efficacy of the tetracaine-oxymetazoline nasal spray for anesthesia of maxillary non-molar teeth
  • > Describe the mechanism of action and effectiveness of buffered local anesthetics
  • > Describe the mechanism of action and efficacy of phentolamine - the local anesthesia reversal agent

Abstract

The dental profession has seen significant advances in its ability to achieve profound pain control more safely. Professor Malamed will discuss recent additions to our pain control armamentarium, including: (1) nasal spray for anesthesia        of maxillary non-molar teeth; (2) buffering of local anesthetics; (3) Computer-Controlled Local Anesthetic Delivery (C-CLAD); (4) Phentolamine mesylate; and (5) Articaine HCl

THREE ADVERSE DRUG INTERACTIONS THAT EVERY DENTIST SHOULD KNOW ABOUT
Elliott Hersh (USA)

Learning Objectives

After attending this presentation, the clinician should be able to:
  • > Discuss the impact of therapeutic index on the severity of adverse drug interactions
  • > Describe the potential drug interaction between epinephrine containing local anesthetics and propranolol
  • > Identify the major group of patients prescribed lithium

Abstract

With polypharmacy being the norm, the potential for serious adverse drug interactions continues to increase in dental practice. Drug with low therapeutic indices such as warfarin and lithium are especially poised to interact severely with commonly prescribed medications such as fluconazole and NSAIDs. While there is fear among clinicians about a multitude of interactions involving epinephrine, the one that is most serious involves patients taking non-selective beta adrenergic blockers such as propranolol. While This stuff seems overwhelming but Dr Hersh is going to“take your hand” and walk you through this complex and potentially litigatious area.

Next Event

FDI 2017
29 August - 1 Septembre 2017
Madrid, Spain

Technical Secretariat

logoGPBlanco  Marià Cubí, 4 | 08006 | Barcelona
  +34 932.388.777
  +34 932.387.488
  This email address is being protected from spambots. You need JavaScript enabled to view it.

Stay Connected on: